142 results on '"Aurrecoechea, Elena"'
Search Results
2. Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients
3. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure
4. SAFETY AND IMMUNOGENICITY OF A PHH-1V BOOSTER DOSE AFTER DIFFERENT PRIME VACCINATION SCHEMES AGAINST COVID-19: PHASE III CLINICAL TRIAL FINAL RESULTS UP TO ONE YEAR
5. Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
6. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)
7. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
8. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
9. O17 SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus, developed from RELESSER prospective database cohort
10. Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
11. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
12. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)
13. Tailoring Rheumatoid Arthritis Treatment through a Sex and Gender Lens
14. Tailoring Rheumatoid Arthritis Treatment through a Gender Lens
15. Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients.
16. Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile
17. LP-171 Fibromyalgia and glucocorticoids use drives self-perceived depression in systemic lupus erythematosus: insights from a large prospective and multicenter study using Relesserpros register’s database.
18. Tailoring Rheumatoid Arthritis Treatment through a Sex and Gender Lens.
19. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA).
20. Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients
21. The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses
22. TNF Inhibitors Exert a “Hidden” Beneficial Effect in the Cardiovascular Lipoprotein Profile of RA Patients
23. Analysis of the rs20541 (R130Q) Polymorphism in the IL-13 Gene in Patients With Elderly-associated Chronic Inflammatory Diseases
24. Análisis del polimorfismo rs20541 (R130Q) del gen de la IL-13 en pacientes con enfermedades inflamatorias crónicas asociadas al envejecimiento
25. Cytokine Gene Considerations in Giant Cell Arteritis: IL10 Promoter Polymorphisms and a Review of the Literature
26. Utilization of hyperestrogenic therapies in systemic lupus erythematosus
27. Utilización de terapias hiperestrogénicas en el lupus eritematoso sistémico
28. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet’s disease: a 1-year follow-up study of 124 patients
29. Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases : Results of the Cardiovascular in Rheumatology (Carma) Project
30. TNF Inhibitors Exert a "Hidden" Beneficial Effect in the Cardiovascular Lipoprotein Profile of RA Patients.
31. Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
32. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
33. Efficacy and safety of switching Jak inhibitors in rheumatoid arthritis: an observational study
34. Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy
35. Construct validity of the ASAS health index in psoriatic arthritis: a cross-sectional analysis
36. Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients
37. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
38. TNF inhibitors exert a “hidden” beneficial effect in the cardiovascular lipoprotein profile of RA patients
39. sj-pdf-1-lup-10.1177_0961203320950477 - Supplemental material for Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
40. sj-pdf-2-lup-10.1177_0961203320950477 - Supplemental material for Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
41. Belimumab in systemic lupus erythematosus: Experience in clinical practice settings in a regional hospital
42. Belimumab en lupus eritematoso sistémico: experiencia en práctica clínica en un hospital comarcal
43. Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry
44. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
45. SAT0219 EFFICACY AND SAFETY OF TOCILIZUMAB IN GIANT CELL ARTERITIS INDEPENDENTLY OF THE INICIAL PREDNISONE DOSE
46. FRI0269 COMPARATIVE STUDY OF INFLIXIMAB VERSUS ADALIMUMAB IN REFRACTORY UVEITIS DUE TO BEHÇET’S DISEASE. NATIONAL MULTICENTER STUDY OF 177 CASES
47. FRI0277 ISCHEMIC AND SYSTEMIC SYMPTOMS IN GIANT CELL ARTERITIS PATIENTS, RESPONSE TO TOCILIZUMAB
48. FRI0276 TIME OF DISEASE EVOLUTION AND EFFICACY OF TOCILIZUMAB IN GIANT CELL ARTERITIS
49. AB1077 ANTI-IL6-RECEPTOR TOCILIZUMAB IN GRAVES’ ORBITOPATHY. MULTICENTER STUDY OF 46 PATIENTS IN CLINICAL PRACTICE
50. THU0292 EXTRACRANIAL VESSEL INVOLVEMENT IN PATIENTS WITH GIANT CELL ARTERITIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.